Amelioration of diabetic dyslipidemia by macrocyclic binuclear oxovanadium complex on streptozotocin induced diabetic rats

Molecular and Cellular Biochemistry

Volumn 272, Issue 1-2, 2005, Pages 157-164

  Ramachandran, Balasubramanian ^a   Subramanian, Sorimuthu ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Dyslipidemia; Fatty acids; Hypercholesterolemia; Hyperlipidemia; Hypolipidemic; Insulin mimetic; Macrocyclic vanadium complex; Streptozotocin diabetes

Indexed keywords

FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXOVANADIUM COMPLEX; STREPTOZOCIN; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; DRUG SYNTHESIS; DYSLIPIDEMIA; GAS CHROMATOGRAPHY; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPID LIVER LEVEL; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; HYPERLIPIDEMIAS; LIPIDS; LIPOPROTEINS; MALE; ORGANOMETALLIC COMPOUNDS; RATS; RATS, WISTAR; VANADIUM COMPOUNDS;

EID: 20944432059     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11010-005-6988-y     Document Type: Article

References (51)

1. O'Brien T, Nguyeen TT, Zimmerman BR: Hyperlipidaemia in diabetes mellitus. Mayo Clin Proc 73: 969, 1998 1:STN:280:DyaK1M%2FgsVSitA%3D%3D
2. McGarry JD: What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258: 766-770, 1992 1:STN:280:ByyD28fis1Q%3D
3. Ebara T, Hirano T, Mamo JC, Sakamaki R, Furukawa S, Nagano S, Takahashi T: Hyperlipidemia in STZ diabetic hamsters as a model for human insulin dependent diabetes mellitus: Comparison to STZ diabetic rats. Metabolism 43: 299-305, 1994 10.1016/0026-0495(94)90096-5
4. Boyd DW, Kustin K: Vanadium: A versatile biochemical effector with an elusive biological function. Adv Inorg Biochem 6: 311-365, 1984 1:CAS:528:DyaL2MXltVSnurY%3D
5. Heyliger EC, Tahiliani GA, McNeill JH: Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227: 1474-1477, 1985 1:CAS:528:DyaL2MXhs1Ckur8%3D
6. Sakurai H, Tsuchiya K, Nukatsuka M, Sofue M, Kawada J: Insulin-like effect of vanadyl ion on streptozotocin diabetic rats. J Endocrinol 124: 451-459, 1990
7. Ramanadham S, Mongold JJ, Brownsey RW, Cors GS, McNeill JH: Oral vanadyl sulphate in treatment of diabetes mellitus in rats. Am J Physiol 257: H904-H911, 1989 1:CAS:528:DyaL1MXls1Oisb4%3D
8. Sekar N, Kanthasamy S, William S, Subramanian S, Govindasamy S: Insulinic action of vanadate on experimental diabetes. Pharmacol Res 22: 207-217, 1990 1:CAS:528:DyaK3cXkslWjtbY%3D
9. Nandhini D, Maneemegalai S, Elangovan V, Sekar N, Govindasamy S: Insulin like effects of bis-glycinato oxovanadium (IV) complex on experimental diabetic rats. Indian J Biochem Biophys 30: 73-76, 1993 1:CAS:528:DyaK3sXhvVeiu70%3D
10. Ramachandran B, Sathish Sekar D, Kandasamy M, Narayanan V, Subramanian S: Hypoglycemic effect of macrocyclic binuclear oxovanadium (IV) complex on streptozotocin induced diabetic rats. Exp Diabesity Res 5: 137-142, 2004 10.1080/15438600490277842
11. Nanda KK, Mohanta SK, Ghosh S, Monika M, Helliwell M, Nag K: Macrocyclic mononuclear VIV and VV, heterodinuclear VV NiV and heterodinuclear VIV Ni II VV complexes: Synthesis, structure, electrochemistry and magneto chemistry. Inorg Chem 34: 2861-2869, 1995 10.1021/ic00115a012
12. Meyerovitch J, Farfel Z, Sack J, Schechter Y: Oral administration of vanadate normalizes blood glucose levels in streptozotocin treated rats. J Biol Chem 262: 6658-6662, 1987 1:CAS:528:DyaL2sXktVSlt78%3D
13. Canepa ET, Llambias EBC, Grinstein M: Studies on regulatory mechanisms of heme biosynthesis in hepatocytes from normal and experimental-diabetic rats. Role of insulin. Biochem Cell Biol 68: 914-921, 1990 1:CAS:528:DyaK3cXkvFGlsbw%3D
14. Folch J, Lees M, Slone Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-509, 1957 1:STN:280:CyiD2srktVE%3D
15. Parekh AC, Jung DH: Cholesterol determination with ferric acetate - uranyl acetate and sulphuric acid - ferrous sulphate reagents. Anal Chem 42: 1423-1427, 1970 10.1021/ac60294a044
16. Foster LB, Dunn RT: Stable reagents for determination of serum triglycerides by a colorimetric Hantzsch condensation method. Clin Chem 19: 338-340, 1973 1:CAS:528:DyaE3sXktFGht7g%3D
17. Itaya K: A more sensitive and stable calorimetric determination of free fatty acids in plasma. J Lip Res 18: 663-665, 1977 1:CAS:528:DyaE2sXls1eksLo%3D
18. Bartlett GR: Phosphorus assay by column chromatography. J Biol Chem 234: 466-468, 1959 1:CAS:528:DyaG1MXmtlWjtg%3D%3D
19. Fiske CH, Subbarow Y: The colorimetric determination of phosphorus. J Biol Chem 66: 375-400, 1925 1:CAS:528:DyaB28XoslGn
20. Burstein M, Scholnick HR: Precipitation of chylomicron and very low density protein from human serum with sodium lauryl sulphate. Life Sci 11: 177-184, 1972 1:CAS:528:DyaE38Xht1erur0%3D
21. Morrison WR, Smith LM: Preparations of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride methanol. J Lipid Res 5: 600-607, 1964 1:CAS:528:DyaF2MXhtVCqtw%3D%3D
22. Howard BV, Abbott WG, Beltz WF, Harper IT, Fields RM, Grundy SM, Taskinen MR: Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes. Metabolism 36: 870-877, 1987 1:STN:280:BiiA3Mvks1U%3D
23. Choi JS, Yokozawa T, Oura H: Improvement of hyperlgycemia and hyperlipemia in streptozotocin-diabetic rats by a methanolic extract of Prumus davidiana stems and its main component,prunin. Planta Med 57: 208-211, 1991 1:CAS:528:DyaK3MXlslCnsLs%3D
24. Sharma SR, Dwivedi SK, Swarup D: Hypoglycemic, antihyperglycemic and hypolipidemic activities of Caesalpinia bonducella seeds in rats. J Ethnopharmacol 58: 39-44, 1997 1:STN:280:ByiH28vhvVY%3D
25. Brichard SM, Ongemba LN, Girard J, Henquin JC: Tissue-specific correction of lipogenic enzyme gene expression in diabetic rats given vanadate. Diabetologia 37: 1065-1072, 1994 1:CAS:528:DyaK2MXitlGlt7c%3D
26. Pugazenthi S, Angel JF, Khandelwal RL: Effects of high sucrose diet on insulin-like effects of vanadate in diabetic rats. Mol Cell Biochem 122: 77-84, 1993 8350867
27. Starzl TE, Francavilla A, Halgrimson CG, Francavilla FR, Porter KA, Brown TH, Putnam CW: Surg Gynaecol Obstet 137: 179-199, 1973 1:CAS:528:DyaE3sXkvFSjurk%3D
28. Mogensen CE, Anderson MJF: Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22: 706-712, 1973 1:STN:280:CSyB2cngs1c%3D
29. Ramachandran B, Ravi K, Narayanan V, Kandaswamy M, Subramanian S: Protective effect of macrocyclic binuclear oxovanadium complex on oxidative stress in pancreas of streptozotocin induced diabetic rats. Chem Biol Interact 149: 9-21, 2004 1:CAS:528:DC%2BD2cXmt1WhtLY%3D
30. Schwarz K, Milne DB: Growth effects of vanadium in the rat. Science 174: 426-428, 1971 1:CAS:528:DyaE38XhtlSjtA%3D%3D
31. Ramachandran B, Kandasamy M, Narayanan V, Subramanian S: Insulin mimetic effects of macrocyclic binuclear oxovanadium complex on STZ-induced experimental diabetes in rats. Diabetes Obes Metab 5: 455-461, 2003 1:CAS:528:DC%2BD2cXltVGr
32. Khan BA, Abraham A, Leelamma S: Hypoglycemic action of Murrya koenigii (curry leaf), Brassica juncea (mustard); mechanism of action. Ind J Biochem Biophys 32: 106-108, 1995 1:CAS:528:DyaK2MXlt1Gjtrw%3D
33. Mitra SK, Gopumadhavan S, Muralidhar TS, Anturlikar SD, Sujatha MB: Effect of D-400, a herbomineral preparation on lipid profile, glycated hemoglobin and glucose tolerance in streptozotocin induced diabetes in rats. Indian J Exp Biol 33: 798-800, 1995 1:CAS:528:DyaK2MXpsVCjt74%3D
34. Al-Shamaony L, Al-Khazraji SM, Twaij HA: Hypoglycemic effect of Artenmisia herba alba 11. Effect of a valuable extract on some blood parameters in diabetic animals. J Ethnopharmacol 43: 167-171, 1994 1:STN:280:ByqD1c3jvVY%3D
35. Savage PJ: Cardiovascular complications of diabetes mellitus: What we know and what we need to know about their prevention. Ann Int Med 124: 123-126, 1996 1:STN:280:BymC2cjit10%3D
36. Nikkila EA, Hormila P: Serum lipids lipoproteins in insulin-treated diabetes demonstration of increased high density lipoprotein concentrations. Diabetes 27: 1078-1086, 1978 1:CAS:528:DyaE1MXjslartw%3D%3D
37. Somogyi A: Diabetes mellitus and lipoproteins. Orv Hetil 134: 2371-2377, 1993 1:STN:280:ByuD2M7hvFM%3D
38. Betteridge DJ: Diabetes, lipoprotein metabolism and atherosclerosis. Br Med Bull 45: 285-311, 1989 1:CAS:528:DyaL1MXhvFSisbw%3D
39. Morita T, Imagawa T, Kanagawa A, Ueki H: Sodium orthovanadate increases phospholipase A2 activity in isolated rats fat pads: A role of phospholipase A2 in the vanadate-stimulated release of lipoprotein lipase activity. Biol Pharm Bull 18: 347-349, 1995 1:CAS:528:DyaK2MXksVWrt7k%3D
40. Ramachandran B, Ravi K, Narayanan V, Kandaswamy M, Subramanian S: Effect of macrocyclic binuclear oxovanadium complex on tissue defense system in streptozotocin induced diabetic rats. Clin Chim Acta 345: 141-150, 2004 1:CAS:528:DC%2BD2cXkvVKks74%3D
41. Setton-Avraj CP, Sterin-Speziale NB: Renal phospholipid metabolism in STZ-induced diabetic rats. Kidney Blood Press Res 19: 128-135, 1996 8871893
42. Lemieux G, Moulin B, Davignon J, Huag YS: The lipid content of diabetic kidney of rat. Can J Physiol Pharmacol 62: 1274-1278, 1984 1:CAS:528:DyaL2cXmtVylsrY%3D
43. KM West 1982 Hyperglycemia as a cause of long term complications In: H. Keen J. Jarret (eds) Complication of diabetes Edward Arnold London 3-18
44. Gupta D, Raju J, Jayaprakash R, Baquer NZ: Change in the lipid profile, lipogenic and related enzymes in the livers of experimental diabetic rats: Effect of insulin and vanadate. Diabetes Res Clin Pract 46: 1-7, 1999 1:CAS:528:DyaK1MXmsVWlsrs%3D
45. Stanely MP, Menon VP, Gunasekaran G: Hypolipidaemic action of Tinospora cordifolia roots in alloxan diabetic rats. J Ethnopharmacol 64: 53-57, 1999 10075122
46. Sekar N, Govindasamy S: Insulin mimetic role of vanadate on plasma membrane insulin receptors. Biochem Int 23: 461-466, 1991 1:CAS:528:DyaK3MXkt1aksLc%3D
47. Goldfine AB, Simonson DC, Folli F, Patti ME, Kahn CR: Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. J Clin Endocrinol Metab 80: 3311-3320, 1995 1:CAS:528:DyaK2MXptleiu7o%3D
48. Holman RT, Johnson SB, Gerrard JM, Maner SM, Kapcho-Sandbeg S, Brown DM: Arachidonic acid deficiency in streptozotocin-induced diabetes. Proc Natl Acad Sci USA 80: 2375-2379, 1983 1:CAS:528:DyaL3sXhvFGqsLs%3D
49. Jones DB, Carter RD, Haitas B, Maan JI: Low phospholipid arachidonic acid values in diabetic platelets. Br Med J 286: 173-175, 1983 1:STN:280:BiyC3c3itFw%3D
50. Tilvis RS, Helve E, Miettinen TA: Improvement of diabetic control by continuous subcutaneous insulin infusion therapy changes fatty acid composition of serum lipids and erythrocytes in type 1 diabetes. Diabetologia 29: 690-694, 1986 1:CAS:528:DyaL2sXksVemsg%3D%3D
51. Cameron NE, Cotter MA: Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res Clin Pract 45: 137-146, 1997